1135 related articles for article (PubMed ID: 28751571)
1. In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing.
Chadwick AC; Wang X; Musunuru K
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1741-1747. PubMed ID: 28751571
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-Cas9 Targeting of PCSK9 in Human Hepatocytes In Vivo-Brief Report.
Wang X; Raghavan A; Chen T; Qiao L; Zhang Y; Ding Q; Musunuru K
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):783-6. PubMed ID: 26941020
[TBL] [Abstract][Full Text] [Related]
3. Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing.
Ding Q; Strong A; Patel KM; Ng SL; Gosis BS; Regan SN; Cowan CA; Rader DJ; Musunuru K
Circ Res; 2014 Aug; 115(5):488-92. PubMed ID: 24916110
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Dyslipidemia Using CRISPR/Cas9 Genome Editing.
Chadwick AC; Musunuru K
Curr Atheroscler Rep; 2017 Jul; 19(7):32. PubMed ID: 28550381
[TBL] [Abstract][Full Text] [Related]
5. In vivo genome and base editing of a human PCSK9 knock-in hypercholesterolemic mouse model.
Carreras A; Pane LS; Nitsch R; Madeyski-Bengtson K; Porritt M; Akcakaya P; Taheri-Ghahfarokhi A; Ericson E; Bjursell M; Perez-Alcazar M; Seeliger F; Althage M; Knöll R; Hicks R; Mayr LM; Perkins R; Lindén D; Borén J; Bohlooly-Y M; Maresca M
BMC Biol; 2019 Jan; 17(1):4. PubMed ID: 30646909
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting
Lee RG; Mazzola AM; Braun MC; Platt C; Vafai SB; Kathiresan S; Rohde E; Bellinger AM; Khera AV
Circulation; 2023 Jan; 147(3):242-253. PubMed ID: 36314243
[TBL] [Abstract][Full Text] [Related]
7. In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates.
Musunuru K; Chadwick AC; Mizoguchi T; Garcia SP; DeNizio JE; Reiss CW; Wang K; Iyer S; Dutta C; Clendaniel V; Amaonye M; Beach A; Berth K; Biswas S; Braun MC; Chen HM; Colace TV; Ganey JD; Gangopadhyay SA; Garrity R; Kasiewicz LN; Lavoie J; Madsen JA; Matsumoto Y; Mazzola AM; Nasrullah YS; Nneji J; Ren H; Sanjeev A; Shay M; Stahley MR; Fan SHY; Tam YK; Gaudelli NM; Ciaramella G; Stolz LE; Malyala P; Cheng CJ; Rajeev KG; Rohde E; Bellinger AM; Kathiresan S
Nature; 2021 May; 593(7859):429-434. PubMed ID: 34012082
[TBL] [Abstract][Full Text] [Related]
8.
Wagner J; Bell AS; Lohoff FW
ACS Chem Neurosci; 2022 Dec; 13(23):3210-3212. PubMed ID: 36374568
[TBL] [Abstract][Full Text] [Related]
9. Gene Editing for the Treatment of Hypercholesterolemia.
Hoekstra M; Van Eck M
Curr Atheroscler Rep; 2024 May; 26(5):139-146. PubMed ID: 38498115
[TBL] [Abstract][Full Text] [Related]
10. A Compact, High-Accuracy Cas9 with a Dinucleotide PAM for In Vivo Genome Editing.
Edraki A; Mir A; Ibraheim R; Gainetdinov I; Yoon Y; Song CQ; Cao Y; Gallant J; Xue W; Rivera-Pérez JA; Sontheimer EJ
Mol Cell; 2019 Feb; 73(4):714-726.e4. PubMed ID: 30581144
[TBL] [Abstract][Full Text] [Related]
11. Long-term stable reduction of low-density lipoprotein in nonhuman primates following in vivo genome editing of PCSK9.
Wang L; Breton C; Warzecha CC; Bell P; Yan H; He Z; White J; Zhu Y; Li M; Buza EL; Jantz D; Wilson JM
Mol Ther; 2021 Jun; 29(6):2019-2029. PubMed ID: 33609733
[TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicle-mediated delivery of CRISPR/Cas9 ribonucleoprotein complex targeting proprotein convertase subtilisin-kexin type 9 (Pcsk9) in primary mouse hepatocytes.
Ilahibaks NF; Kluiver TA; de Jong OG; de Jager SCA; Schiffelers RM; Vader P; Peng WC; Lei Z; Sluijter JPG
J Extracell Vesicles; 2024 Jan; 13(1):e12389. PubMed ID: 38191764
[TBL] [Abstract][Full Text] [Related]
13. CES1-Triggered Liver-Specific Cargo Release of CRISPR/Cas9 Elements by Cationic Triadic Copolymeric Nanoparticles Targeting Gene Editing of PCSK9 for Hyperlipidemia Amelioration.
Zhao Y; Li Y; Wang F; Gan X; Zheng T; Chen M; Wei L; Chen J; Yu C
Adv Sci (Weinh); 2023 Jul; 10(19):e2300502. PubMed ID: 37083231
[TBL] [Abstract][Full Text] [Related]
14. Eliminating base-editor-induced genome-wide and transcriptome-wide off-target mutations.
Wang L; Xue W; Zhang H; Gao R; Qiu H; Wei J; Zhou L; Lei YN; Wu X; Li X; Liu C; Wu J; Chen Q; Ma H; Huang X; Cai C; Zhang Y; Yang B; Yin H; Yang L; Chen J
Nat Cell Biol; 2021 May; 23(5):552-563. PubMed ID: 33972728
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
Kim EJ; Kang KH; Ju JH
Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
[TBL] [Abstract][Full Text] [Related]
16. Somatic Editing of Ldlr With Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis Research.
Jarrett KE; Lee C; De Giorgi M; Hurley A; Gillard BK; Doerfler AM; Li A; Pownall HJ; Bao G; Lagor WR
Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):1997-2006. PubMed ID: 30026278
[TBL] [Abstract][Full Text] [Related]
17. Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol.
Xu YX; Redon V; Yu H; Querbes W; Pirruccello J; Liebow A; Deik A; Trindade K; Wang X; Musunuru K; Clish CB; Cowan C; Fizgerald K; Rader D; Kathiresan S
Atherosclerosis; 2018 Jan; 268():196-206. PubMed ID: 29183623
[TBL] [Abstract][Full Text] [Related]
18. Meganuclease targeting of PCSK9 in macaque liver leads to stable reduction in serum cholesterol.
Wang L; Smith J; Breton C; Clark P; Zhang J; Ying L; Che Y; Lape J; Bell P; Calcedo R; Buza EL; Saveliev A; Bartsevich VV; He Z; White J; Li M; Jantz D; Wilson JM
Nat Biotechnol; 2018 Sep; 36(8):717-725. PubMed ID: 29985478
[TBL] [Abstract][Full Text] [Related]
19. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-Mediated Gene Editing in Human iPSC-Derived Macrophage Reveals Lysosomal Acid Lipase Function in Human Macrophages-Brief Report.
Zhang H; Shi J; Hachet MA; Xue C; Bauer RC; Jiang H; Li W; Tohyama J; Millar J; Billheimer J; Phillips MC; Razani B; Rader DJ; Reilly MP
Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2156-2160. PubMed ID: 28882870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
